86 related articles for article (PubMed ID: 8575602)
1. Repetitive, low-dose tissue plasminogen activator for clearance of experimental vitreous hemorrhage.
Zhao P; Wang W; Song H; Zhu Y
Yan Ke Xue Bao; 1995 Mar; 11(1):29-31, 40. PubMed ID: 8575602
[TBL] [Abstract][Full Text] [Related]
2. Repetitive low-dose tissue plasminogen activator for the clearance of experimental vitreous hemorrhage.
Min WK; Kim YB; Ahn BH; Seong GH
Korean J Ophthalmol; 1994 Dec; 8(2):45-8. PubMed ID: 7853730
[TBL] [Abstract][Full Text] [Related]
3. Treatment of experimental vitreous hemorrhage with tissue plasminogen activator.
Min WK; Kim YB; Lee KM
Korean J Ophthalmol; 1990 Jun; 4(1):12-5. PubMed ID: 2120486
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal tissue plasminogen activator treatment of experimental vitreous hemorrhage.
Johnson RN; Olsen KR; Hernandez E
Arch Ophthalmol; 1989 Jun; 107(6):891-4. PubMed ID: 2499298
[TBL] [Abstract][Full Text] [Related]
5. Induction of posterior vitreous detachment in rabbits by intravitreal injection of tissue plasminogen activator following cryopexy.
Hesse L; Nebeling B; Schroeder B; Heller G; Kroll P
Exp Eye Res; 2000 Jan; 70(1):31-9. PubMed ID: 10644418
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal and subretinal injection of tissue plasminogen activator (tPA) in the treatment of experimentally created retinal vein occlusion in rabbits.
Ameri H; Kim JG; Ratanapakorn T; Chader GJ; Humayun MS
Retina; 2008 Feb; 28(2):350-5. PubMed ID: 18301042
[TBL] [Abstract][Full Text] [Related]
7. Effect of intravitreal tissue plasminogen activator on experimental subretinal hemorrhage.
Coll GE; Sparrow JR; Marinovic A; Chang S
Retina; 1995; 15(4):319-26. PubMed ID: 8545578
[TBL] [Abstract][Full Text] [Related]
8. A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits.
Kamei M; Misono K; Lewis H
Am J Ophthalmol; 1999 Dec; 128(6):739-46. PubMed ID: 10612511
[TBL] [Abstract][Full Text] [Related]
9. Management of submacular hemorrhage with intravitreal injection of tissue plasminogen activator and expansile gas.
Chen CY; Hooper C; Chiu D; Chamberlain M; Karia N; Heriot WJ
Retina; 2007 Mar; 27(3):321-8. PubMed ID: 17460587
[TBL] [Abstract][Full Text] [Related]
10. Resolution of experimental intravitreal fibrin by tissue plasminogen activator.
Min WK; Kim YB
Korean J Ophthalmol; 1990 Dec; 4(2):58-65. PubMed ID: 2128708
[TBL] [Abstract][Full Text] [Related]
11. The role of intravitreal bevacizumab in experimental posterior penetrating eye injury.
Mehdizadeh M; Fattahi F; Eghtedari M; Nowroozzadeh MH; Toosi F
Retina; 2011 Jan; 31(1):154-60. PubMed ID: 20838359
[TBL] [Abstract][Full Text] [Related]
12. Treatment of submacular hemorrhage with low-dose intravitreal tissue plasminogen activator injection and pneumatic displacement.
Handwerger BA; Blodi BA; Chandra SR; Olsen TW; Stevens TS
Arch Ophthalmol; 2001 Jan; 119(1):28-32. PubMed ID: 11146723
[TBL] [Abstract][Full Text] [Related]
13. Retinal toxicity of commercial intravitreal tissue plasminogen activator solution in cat eyes.
Hrach CJ; Johnson MW; Hassan AS; Lei B; Sieving PA; Elner VM
Arch Ophthalmol; 2000 May; 118(5):659-63. PubMed ID: 10815158
[TBL] [Abstract][Full Text] [Related]
14. Retinal Penetration of Intravitreally Injected Tissue Plasminogen Activator: A Rat Model Study.
Tal K; Dotan A; Nisgav Y; Dachbash M; Gal-Or O; Ehrlich R; Gaton DD; Weinberger D; Livnat T
Ophthalmic Res; 2018; 59(4):235-240. PubMed ID: 28728144
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal r-TPA and gas injection in traumatic submacular hemorrhage.
Holland D; Wiechens B
Ophthalmologica; 2004; 218(1):64-9. PubMed ID: 14688438
[TBL] [Abstract][Full Text] [Related]
16. Vitreous hemorrhage complicating intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage.
Wu TT; Kung YH; Hong MC
Retina; 2011 Nov; 31(10):2071-7. PubMed ID: 21817964
[TBL] [Abstract][Full Text] [Related]
17. Effect of microplasmin on the clearance of vitreous haemorrhage from an experimental model in rabbits.
Gad Elkareem AM; de Smet MD
Acta Ophthalmol; 2014 Feb; 92(1):47-50. PubMed ID: 23025384
[TBL] [Abstract][Full Text] [Related]
18. Management of postvitrectomy diabetic vitreous hemorrhage with tissue plasminogen activator (t-PA) and volume homeostatic fluid-fluid exchanger.
Wu WC; Chang SM; Chen JY; Chang CW
J Ocul Pharmacol Ther; 2001 Aug; 17(4):363-71. PubMed ID: 11572467
[TBL] [Abstract][Full Text] [Related]
19. Comparison of pneumatic displacement for submacular hemorrhages with gas alone and gas plus tissue plasminogen activator.
Fujikawa M; Sawada O; Miyake T; Kakinoki M; Sawada T; Kawamura H; Sakaguchi H; Gomi F; Ohji M
Retina; 2013 Oct; 33(9):1908-14. PubMed ID: 23594720
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo).
Diakonis VF; Tsourdou A; Tzatzarakis MN; Tsika C; Charisis S; Naoumidi I; Plainis S; Tsilimbaris MK
J Ocul Pharmacol Ther; 2013 Sep; 29(7):627-32. PubMed ID: 23556534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
